John L Higgins's Net Worth
$58.9 Million
Estimate Recalculated Apr 26, 2024 05:37PM EST
Who is John L Higgins?
John L Higgins has an estimated net worth of $58.9 Million. This is based on reported shares across multiple companies, which include OmniAb, Inc., BIO-TECHNE Corp, LIGAND PHARMACEUTICALS INC, BIOCRYST PHARMACEUTICALS INC, and CONNETICS CORP.
SEC CIK
John L Higgins's CIK is 0001208906
Past Insider Trading and Trends
2022 was John L Higgins's most active year for acquiring shares with 26 total transactions. John L Higgins's most active month to acquire stocks was the month of September. 2022 was John L Higgins's most active year for disposing of shares, totalling 23 transactions. John L Higgins's most active month to dispose stocks was the month of July. 2012 saw John L Higgins paying a total of $2,324,837.02 for 186,666 shares, this is the most they've acquired in one year. In 2018 John L Higgins cashed out on 20,000 shares for a total of $1,879,173.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
OmniAb, Inc. (OABI) Snapshot price: $5.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +1,378.65% | 2.43M |
—
|
—
| 2.6M |
Nov 1
| |||
Form 4
| +0.56% | 13.17K |
—
|
—
| 2.35M |
Jan 30
| |||
Form 4
| +3.53% | 83.72K |
$3.36 | $281,548.93 | 2.34M |
Dec 28 - Jun 23
| |||
Form 4
|
—
|
0
|
$3.87 | -$3,330.00 | 2.46M |
May 23
| |||
Form 4
|
—
|
0
|
$3.87 | -$370.00 | 2.46M |
May 19
| |||
Form 4
|
—
|
0
|
$3.79 | -$10,500.00 | 2.46M |
May 18
| |||
Form 4
| +1.63% | 39.52K |
—
|
—
| 2.46M |
Jan 30
| |||
Form 4
|
∞
| 2.42M |
$2.52 |
—
| 2.42M |
Nov 1 - Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIO-TECHNE Corp (TECH) Snapshot price: $66.465
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.65% | 1.63K |
—
|
—
| 36.61K |
Oct 26
| |||
Form 4
| +49.76% | 11.62K |
$50.86 | -$34.76 | 34.98K |
Apr 28
| |||
Form 4
| +6.14% | 338 |
—
|
—
| 5.84K |
Oct 27
| |||
Form 4
| +19.45% | 896 |
$222.85 | -$721,056.15 | 5.5K |
Aug 10 - Aug 11
| |||
Form 4
|
—
|
0
|
$215.94 | -$476,924.00 | 4.61K |
Jun 7 - Jun 8
| |||
Form 4
| +4.40% | 194 |
—
|
—
| 4.61K |
Oct 28
| |||
Form 4
|
—
|
0
|
$185.35 | -$1,149,994.13 | 4.41K |
Nov 6
| |||
Form 4
| +9.72% | 391 |
—
|
—
| 4.41K |
Oct 29
| |||
Form 4
|
—
|
0
|
$133.35 | -$718,832.50 | 4.02K |
Feb 12
| |||
Form 4
| +14.04% | 495 |
—
|
—
| 4.02K |
Oct 24
| |||
Form 4
|
—
|
0
|
$133.35 | -$703,195.50 | 3.53K |
Jun 4
| |||
Form 4
| +17.07% | 514 |
—
|
—
| 3.53K |
Oct 25
| |||
Form 4
|
—
|
0
|
$124.50 | -$1,268,373.00 | 3.01K |
Aug 23
| |||
Form 4
| +32.51% | 739 |
—
|
—
| 3.01K |
Oct 26
| |||
Form 4
| +67.26% | 914 |
—
|
—
| 2.27K |
Oct 27
| |||
Form 4
| -55.57% | -1.70K |
$109.83 | -$186,715.93 | 1.36K |
Sep 8
| |||
Form 4
| +52.95% | 1.06K |
—
|
—
| 3.06K |
Oct 29
| |||
Form 4
| +100.00% | 1K |
—
|
—
| 2K |
Oct 30
| |||
Form 4
|
∞
| 1K |
—
|
—
| 1K |
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $74.72
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.25% | -5.29K |
$66.29 | -$350,607.81 | 417.69K |
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
| -2.31% | -10.00K |
$61.87 | -$618,657.00 | 422.98K |
Scheduled
|
Dec 16
| ||
Form 4
| +3.85% | 16.06K |
$38.79 | $28.80 | 432.98K |
Dec 12
| |||
Form 4
| -2.30% | -9.80K |
$72.90 | -$714,638.70 | 416.93K |
Nov 30
| |||
Form 4
|
—
|
0
|
$45.55 | -$655,373.00 | 426.73K |
Scheduled
|
Nov 17 - Nov 18
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +12.12% | 45.92K |
—
|
—
| 424.73K |
Nov 1
| |||
Form 4/A
| -0.27% | -1.00K |
$88.06 | -$88,060.00 | 366.18K |
Sep 16
| |||
Form 4
| -1.35% | -5.00K |
$89.61 | -$448,050.00 | 364.18K |
Sep 15 - Sep 16
| |||
Form 4
| +0.04% | 164 |
$75.84 | $12,437.27 | 369.18K |
Jun 30
| |||
Form 4
| +5.86% | 20.42K |
—
|
—
| 369.02K |
Jun 10
| |||
Form 4
| +2.35% | 8K |
$21.92 | $175,360.00 | 348.59K |
May 9 - May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 4/A
| +6.72% | 6K |
—
|
—
| 95.28K |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOCRYST PHARMACEUTICALS INC (BCRX) Snapshot price: $5.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONNETICS CORP No price found
EVP, Finance, Corp Dev. & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -114.37K |
$17.50 | -$2,001,492.50 |
0
|
Dec 28 - Dec 29
| |||
Form 4
| -4.99% | -6.00K |
—
|
—
| 114.12K |
Dec 21
| |||
Form 4
| +81.96% | 60.86K |
—
| $60.86 | 135.12K |
Feb 1
| |||
Form 4
| +8.48% | 5.81K |
$6.03 | $35,030.99 | 74.26K |
Sep 2
| |||
Form 4
|
—
|
0
|
$10.89 | -$205,241.83 | 68.45K |
Scheduled
|
Aug 22
| ||
Form 4
| -12.75% | -10.00K |
$20.71 | -$207,073.00 | 68.45K |
Scheduled
|
Jun 10
| ||
Form 4
| -1.45% | -1.15K |
$18.40 | -$21,236.48 | 78.45K |
May 31
| |||
Form 4
|
—
|
0
|
$16.13 | -$128,750.00 | 77.3K |
Scheduled
|
Apr 19
| ||
Form 4
|
—
|
0
|
$15.60 | -$98,800.00 | 77.3K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
$13.01 | -$243,875.00 | 167.09K |
Scheduled
|
Jan 14
| ||
Form 4
| +1.15% | 881 |
$10.30 | $9,076.06 | 77.3K |
Nov 30
| |||
Form 4
|
—
|
0
|
$17.08 | -$122,720.44 | 317.65K |
Scheduled
|
Nov 10
| ||
Form 4
| -8.94% | -7.50K |
$26.62 | -$199,662.75 | 76.42K |
Scheduled
|
Nov 1
| ||
Form 4
| +14.22% | 10.45K |
$15.68 | -$774,697.71 | 83.92K |
Scheduled
|
Jul 30 - Aug 2
| ||
Form 4
| -11.98% | -10.00K |
$20.77 | -$207,739.00 | 73.47K |
Scheduled
|
Jun 15
| ||
Form 4
| +2.80% | 2.27K |
$10.30 | $23,437.05 | 83.47K |
May 28
| |||
Form 4
|
—
|
0
|
$15.56 | -$68,069.00 | 81.19K |
Scheduled
|
Mar 12
| ||
Form 4
| +35.22% | 21.15K |
$12.94 | -$3.05 | 81.19K |
Feb 20
| |||
Form 4
|
—
|
0
|
$16.98 | -$246,720.00 | 60.05K |
Scheduled
|
Feb 9
| ||
Form 4
| -24.98% | -15.00K |
$12.57 | -$477,699.00 | 45.05K |
Scheduled
|
Jan 20 - Jan 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| -3.51% | -2.18K |
$10.30 | -$22,499.57 | 60.05K |
Nov 28
| |||
Form 4
| -14.74% | -10.00K |
$19.00 | -$190,000.00 | 57.86K |
Scheduled
|
Oct 14
| ||
Form 4
| +32.30% | 16.63K |
$11.32 | -$1.52 | 68.11K |
Sep 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||